From the ALK kinase domain, two HLA-A2.1 restricted CD8+ T-cell epitopes, p280–289 (SLAMLDLLHV) and p375–389 (GVLLWEIFSL) were identified and confirmed to be immunogenic in HLA-matched ALCL and neuroblastoma cell lines [77]. The gene discussed is ALK; the disease is neuroblastoma.